γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia

被引：20

作者：

Luong-Gardiol, Noemie ^{[1
,8
]}

Siddiqui, Imran ^{[1
]}

Pizzitola, Irene ^{[1
]}

Jeevan-Raj, Beena ^{[1
]}

Charmoy, Melanie ^{[1
]}

Huang, Yun ^{[2
,3
]}

Irmisch, Anja ^{[4
,9
]}

Curtet, Sara ^{[1
]}

Angelov, Georgi S. ^{[1
]}

Danilo, Maxime ^{[1
,10
]}

Juilland, Melanie ^{[5
]}

Bornhauser, Beat ^{[2
,3
]}

Thome, Margot ^{[5
]}

Hantschel, Oliver ^{[4
]}

Chalandon, Yves ^{[6
]}

Cazzaniga, Gianni ^{[7
]}

Bourquin, Jean-Pierre ^{[2
,3
]}

Huelsken, Joerg ^{[4
]}

Held, Werner ^{[1
]}

机构：

[1] Univ Lausanne, Dept Oncol UNIL CHUV, Epalinges, Switzerland

[2] Univ Childrens Hosp Zurich, Dept Pediat Oncol, Zurich, Switzerland

[3] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland

[4] Fed Univ Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland

[5] Univ Lausanne, Dept Biochem, Epalinges, Switzerland

[6] Hop Univ Geneve, Serv Hematol, Geneva, Switzerland

[7] Pediat Clin Univ Milano Bicocca, Ctr Ric Tettamanti, Monza, Italy

[8] Debiopharm Int SA, Ch Messidor 5-7, CH-1002 Lausanne, Switzerland

[9] Univ Hosp Zurich, Clin Dermatol, Wagistr 14, CH-8952 Schlieren, Switzerland

[10] Phi Pharma SA, Pl Midi 36, CH-1950 Sion, Switzerland

来源：

CANCER CELL | 2019年 / 35卷 / 04期

基金：

瑞士国家科学基金会;

关键词：

CHRONIC MYELOID-LEUKEMIA; BETA-CATENIN; STEM-CELLS; C-MYC; BCR-ABL; TRANSCRIPTIONAL REGULATION; TRANSLOCATION PRODUCTS; SURVIVIN; PATHWAY; KINASE;

D O I：

10.1016/j.ccell.2019.03.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The BCR-ABL1 fusion protein is the cause of chronic myeloid leukemia (CML) and of a significant fraction of adult-onset B cell acute lymphoblastic leukemia (B-ALL) cases. Using mouse models and patient-derived samples, we identified an essential role for gamma-catenin in the initiation and maintenance of BCR-ABL1(+) B-ALL but not CML. The selectivity was explained by a partial gamma-catenin dependence of MYC expression together with the susceptibility of B-ALL, but not CML, to reduced MYC levels. MYC and gamma-catenin enabled B-ALL maintenance by augmenting BIRC5 and enforced BIRC5 expression overcame gamma-catenin loss. Since gamma-catenin was dispensable for normal hematopoiesis, these lineage- and disease-specific features of canonical Wnt signaling identified a potential therapeutic target for the treatment of BCR-ABL1(+) B-ALL.

引用

页码：649 / +

页数：25

共 50 条

[21] BCR-ABL rearrangement in adult T-cell acute lymphoblastic leukemia
Colleoni, GWB
Yamamoto, M
Kerbauy, J
Serafim, RC
Lindsey, CJ
Costa, FF
Grignolli, CRE
Saad, STO
AMERICAN JOURNAL OF HEMATOLOGY, 1996, 53 (04) : 277 - 278
[22] Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia
Chong, Siew Lian
Asnawi, Asral Wirda Ahmad
Leong, Tze Shin
Tan, Jenq Tzong
Law, Kian Boon
Hon, Siong Leng
Fann, Rui Jeat
Tan, Sen Mui
BLOOD RESEARCH, 2021, 56 (03) : 175 - 183
[23] A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
Ingeborg Menzl
Tinghu Zhang
Angelika Berger-Becvar
Reinhard Grausenburger
Gerwin Heller
Michaela Prchal-Murphy
Leo Edlinger
Vanessa M. Knab
Iris Z. Uras
Eva Grundschober
Karin Bauer
Mareike Roth
Anna Skucha
Yao Liu
John M. Hatcher
Yanke Liang
Nicholas P. Kwiatkowski
Daniela Fux
Andrea Hoelbl-Kovacic
Stefan Kubicek
Junia V. Melo
Peter Valent
Thomas Weichhart
Florian Grebien
Johannes Zuber
Nathanael S. Gray
Veronika Sexl
Nature Communications, 10
[24] BCR/ABL1-like acute lymphoblastic leukemia: How to diagnose and treat?
Chiaretti, Sabina
Messina, Monica
Foa, Robin
CANCER, 2019, 125 (02) : 194 - 204
[25] BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
Cario, Gunnar
Leoni, Veronica
Conter, Valentino
Baruchel, Andre
Schrappe, Martin
Biondi, Andrea
HAEMATOLOGICA, 2020, 105 (09) : 2200 - 2204
[26] Entire ABL1 Gene Deletion Without BCR/ABL1 Rearrangement in a Female Patient with B-Cell Precursor Acute Lymphoblastic Leukemia
Jiang, Yijing
Zhang, Jie
Guo, Dan
Zhang, Chenlu
Hong, Lemin
Huang, Hongming
Liu, Haiyan
ONCOTARGETS AND THERAPY, 2020, 13 : 783 - 790
[27] Mucin 4 protein is expressed in B-acute lymphoblastic leukemia and is restricted to BCR::ABL1-positive and BCR::ABL-like subtypes*
Gestrich, Catherine K.
De Lancy, Shanelle J.
Kresak, Adam
Sinno, Mohamad G.
Yalley, Akua
Pateva, Irina
Meyerson, Howard
Shetty, Shashirekha
Oduro Jr, Kwadwo A.
HUMAN PATHOLOGY, 2023, 136 : 75 - 83
[28] A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
Menzl, Ingeborg
Zhang, Tinghu
Berger-Becvar, Angelika
Grausenburger, Reinhard
Heller, Gerwin
Prchal-Murphy, Michaela
Edlinger, Leo
Knab, Vanessa M.
Uras, Iris Z.
Grundschober, Eva
Bauer, Karin
Roth, Mareike
Skucha, Anna
Liu, Yao
Hatcher, John M.
Liang, Yanke
Kwiatkowski, Nicholas P.
Fuxl, Daniela
Hoelbl-Kovacic, Andrea
Kubicek, Stefan
Melo, Junia, V
Valent, Peter
Weichhart, Thomas
Grebien, Florian
Zuber, Johannes
Gray, Nathanael S.
Sexl, Veronika
NATURE COMMUNICATIONS, 2019, 10 (1)
[29] Very rare lineage switch from acute myeloid leukemia with BCR-ABL1 to B-lymphoblastic leukemia
Li, Ting
Chen, Hongwei
Zhang, Yun
Zeng, Yuxiao
Zheng, Liheng
ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1635 - 1636
[30] Very rare lineage switch from acute myeloid leukemia with BCR-ABL1 to B-lymphoblastic leukemia
Ting Li
Hongwei Chen
Yun Zhang
Yuxiao Zeng
Liheng Zheng
Annals of Hematology, 2021, 100 : 1635 - 1636

← 1 2 3 4 5 →